TEAS RF New Application

NUZYRA

Paratek Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88438211
Filing Date: 05/20/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88438211
MARK INFORMATION
*MARK NUZYRA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NUZYRA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Paratek Pharmaceuticals, Inc.
*STREET 75 Park Plaza
*CITY Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02116
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 036 
*IDENTIFICATION Insurance consultancy services in the field of health; Insurance services, namely, insurance eligibility review and verification and consultation in the pharmaceutical industry; Pharmaceutical benefit management services; Insurance administration services, namely, assisting others with applying for insurance benefits
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 039 
*IDENTIFICATION Transportation of goods, namely, antibiotics; delivery and storage of goods; delivery of pharmaceuticals
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; Medical information services, namely, providing information to physicians, healthcare professionals, and patients on the topics of health issues, pharmaceutical products, and health awareness in the field of infectious diseases; Health care services, namely, providing patient access programs to provide eligible patients with streamlined access to drugs; Dispensing of pharmaceuticals; Providing an internet website for medical professionals and medical patients featuring medical information that enables users to enter, access, track, monitor and generate health and medical information
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 02/14/2019
       FIRST USE IN COMMERCE DATE At least as early as 02/14/2019
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-63764866-20190517172542619181_._NUZYRA_-_Class_44_Specimen.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT17\IMAGEOUT17\884\382\88438211\xml1\RFA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\884\382\88438211\xml1\RFA0004.JPG
       SPECIMEN DESCRIPTION the mark shown on the applicant's website in relation to the services
ATTORNEY INFORMATION
NAME Keith Toms, Esq.
FIRM NAME McCarter & English, LLP
STREET 265 Franklin Street
CITY Boston
STATE Massachusetts
COUNTRY United States
ZIP/POSTAL CODE 02110
PHONE 617-449-6500
FAX 617-607-9200
EMAIL ADDRESS ktoms@mccarter.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Quincy L. Kayton, Esq., Aya Cieslak-Tochigi, Esq., Jin Wang, Esq., Kritika Bharadwaj, Esq.
CORRESPONDENCE INFORMATION
NAME Keith Toms, Esq.
FIRM NAME McCarter & English, LLP
STREET 265 Franklin Street
CITY Boston
STATE Massachusetts
COUNTRY United States
ZIP/POSTAL CODE 02110
PHONE 617-449-6500
FAX 617-607-9200
*EMAIL ADDRESS ktoms@mccarter.com; bostontrademarks@mccarter.com; qkayton@mccarter.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 825
*TOTAL FEE PAID 825
SIGNATURE INFORMATION
SIGNATURE /Susan M. Perkins/
SIGNATORY'S NAME Susan M. Perkins
SIGNATORY'S POSITION Vice President, Intellectual Property
SIGNATORY'S PHONE NUMBER 000-000-0000
DATE SIGNED 05/20/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88438211
Filing Date: 05/20/2019

To the Commissioner for Trademarks:

MARK: NUZYRA (Standard Characters, see mark)
The literal element of the mark consists of NUZYRA.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Paratek Pharmaceuticals, Inc., a corporation of Delaware, having an address of
      75 Park Plaza
      Boston, Massachusetts 02116
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 036:  Insurance consultancy services in the field of health; Insurance services, namely, insurance eligibility review and verification and consultation in the pharmaceutical industry; Pharmaceutical benefit management services; Insurance administration services, namely, assisting others with applying for insurance benefits
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 039:  Transportation of goods, namely, antibiotics; delivery and storage of goods; delivery of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 044:  Providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; Medical information services, namely, providing information to physicians, healthcare professionals, and patients on the topics of health issues, pharmaceutical products, and health awareness in the field of infectious diseases; Health care services, namely, providing patient access programs to provide eligible patients with streamlined access to drugs; Dispensing of pharmaceuticals; Providing an internet website for medical professionals and medical patients featuring medical information that enables users to enter, access, track, monitor and generate health and medical information

In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/14/2019, and first used in commerce at least as early as 02/14/2019, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) the mark shown on the applicant's website in relation to the services.

Original PDF file:
SPE0-63764866-20190517172542619181_._NUZYRA_-_Class_44_Specimen.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2


The applicant's current Attorney Information:
      Keith Toms, Esq. and Quincy L. Kayton, Esq., Aya Cieslak-Tochigi, Esq., Jin Wang, Esq., Kritika Bharadwaj, Esq. of McCarter & English, LLP      265 Franklin Street
      Boston, Massachusetts 02110
      United States
      617-449-6500(phone)
      617-607-9200(fax)
      ktoms@mccarter.com (authorized)

The applicant's current Correspondence Information:
      Keith Toms, Esq.
      McCarter & English, LLP
      265 Franklin Street
      Boston, Massachusetts 02110
      617-449-6500(phone)
      617-607-9200(fax)
      ktoms@mccarter.com;bostontrademarks@mccarter.com;qkayton@mccarter.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Susan M. Perkins/   Date: 05/20/2019
Signatory's Name: Susan M. Perkins
Signatory's Position: Vice President, Intellectual Property
Payment Sale Number: 88438211
Payment Accounting Date: 05/21/2019

Serial Number: 88438211
Internet Transmission Date: Mon May 20 15:33:33 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XX.XX.XX-201905201533337690
08-88438211-620753a3cf7af13d72e7a589b989
d2cdd9e463613c182179f8e9f337e858e2ad93-D
A-2069-20190517172542619181

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed